GENOPTIC Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Genoptic, and what generic alternatives are available?
Genoptic is a drug marketed by Allergan and is included in one NDA.
The generic ingredient in GENOPTIC is gentamicin sulfate. There are fifteen drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the gentamicin sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Genoptic
A generic version of GENOPTIC was approved as gentamicin sulfate by SANDOZ on December 31st, 1969.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for GENOPTIC?
- What are the global sales for GENOPTIC?
- What is Average Wholesale Price for GENOPTIC?
Summary for GENOPTIC
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 6 |
| Raw Ingredient (Bulk) Api Vendors: | 31 |
| DailyMed Link: | GENOPTIC at DailyMed |
Pharmacology for GENOPTIC
| Drug Class | Aminoglycoside Antibacterial |
US Patents and Regulatory Information for GENOPTIC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Allergan | GENOPTIC | gentamicin sulfate | SOLUTION/DROPS;OPHTHALMIC | 062452-001 | Oct 10, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
